Loading organizations...
Paul Capital is a private equity investment firm specializing in secondary investments, fund of funds, and healthcare direct investments. It provides liquidity solutions in the private equity market by acquiring interests in private equity funds and direct company stakes. The firm integrates these three distinct platforms to deliver tailored strategies.
Philip Paul founded the firm in 1991. His insight stemmed from an early acquisition of a substantial portfolio of venture capital and leveraged buyout fund positions from the Hillman Company. This pioneering transaction predated the formal private equity secondary market, highlighting Paul's foresight for liquidity in illiquid assets and shaping the firm's specialized focus.
The firm serves institutional investors, including pension funds, financial institutions, and endowments. Paul Capital's vision involves offering unique insights and developing compelling solutions to address complex investor needs, fostering liquidity within private equity portfolios. It aims to facilitate early exits for sellers while considering relationships and future upside.
Paul Capital has 3 tracked investments across 3 companies. The latest tracked deal is $12.5M Other Equity in Carbon Black in April 2011.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Apr 12, 2011 | Carbon Black | $12.5M Other Equity | Jeff Fagnan | .406 Ventures, Highland Capital Partners, Kleiner Perkins |
| Feb 1, 2011 | Recyclebank | $14.0M Series C | — | Cathay Innovation, Great Oaks Venture Capital, Gutbrain Ventures, Innovation Endeavors, Interlock Partners, Montage Ventures, NFX, Pear VC, RRE Ventures, Techstars, WestCap, Kleiner Perkins, Physic Ventures, Sigma Partners, The Westly Group |
| Jul 21, 2010 | Tethys BioScience | $33.0M Debt / Series D | — | Greenspring Associates, Oxford Finance, Silicon Valley Bank |
